Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis : Episode 5

Exploring the Role of Non-Pharmacological Modalities and Multidisciplinary Care in Patients with Idiopathic and Progressive Pulmonary Fibrosis

August 1, 2024

Opinion

Video

Dr. Paul Frohna discusses the importance of non-pharmacological modalities, as well as utilizing multidisciplinary care, for patients with idiopathic and progressive pulmonary fibrosis.

EP: 1.Symptoms, Manifestations and Mortality Rate of IPF

EP: 2.How the GAP Program Helps Determine Patient Prognosis, and Risk Factors for Developing IPF/PPF

EP: 3.Epidemiology Facts, Differential Diagnosis, and Arriving at a IPF or PPF Diagnosis

EP: 4.Critical Early Diagnoses and Acute Exacerbations in IPF and PPF

Now Viewing

EP: 5.Exploring the Role of Non-Pharmacological Modalities and Multidisciplinary Care in Patients with Idiopathic and Progressive Pulmonary Fibrosis

EP: 6.Managing Acute Exacerbations and the Psychosocial Aspect of Idiopathic and Progressive Pulmonary Fibrosis

EP: 7.Key Unmet Needs Associated with Idiopathic and Progressive Pulmonary Fibrosis

EP: 8.The Roles of Biomarker Testing and HRCT in IPF and PPF

EP: 9.Unmet Needs and the Role of AI in Earlier Disease Detection

EP: 10.Adverse Events Associated with Anti-Fibrotic Therapies

EP: 11.Investigational Agents for Idiopathic and Progressive Pulmonary Fibrosis

EP: 12.The Future of Idiopathic and Progressive Pulmonary Fibrosis Treatment

EP: 13.K-Cast Written Summary. Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis

What are some of the nonpharmacological modalities that should be used once a patient is diagnosed with IPF/PPF?
How can multidisciplinary care be optimized when treating patients with IPF/PPF?

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!